Nightingale Pharmaceuticals, Inc. — Form D
Nightingale Pharmaceuticals, Inc. of NATIONAL CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-06. The offering totals $2.0M, of which $375K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-03-06
- Form: D
- Accession: 0001078782-15-000357
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $375K
- Remaining: $1.6M
- Minimum investment: $125K
- Investors: 1
- Date of first sale: 2015-02-27
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-235337
Issuer
- Name: Nightingale Pharmaceuticals, Inc.
- CIK: 0001635548
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2015
- Address: 1999 SWEETWATER RD., NATIONAL CITY, CA, 91950
- Phone: 760-522-3345
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| TALAL (BRIAN) SHEENA | Director | NATIONAL CITY, CA |
| TALAL (BRIAN) SHEENA | Executive Officer | NATIONAL CITY, CA |
| DAVID CHURCH | Director | NATIONAL CITY, CA |
| DAVID CHURCH | Executive Officer | NATIONAL CITY, CA |
| LORENS ATTISHA | Director | NATIONAL CITY, CA |
| LORENS ATTISHA | Executive Officer | NATIONAL CITY, CA |
| CAROL MCBRIDE | Director | NATIONAL CITY, CA |
| CAROL MCBRIDE | Executive Officer | NATIONAL CITY, CA |
| MELWYN ABREO | Director | NATIONAL CITY, CA |
| MELWYN ABREO | Executive Officer | NATIONAL CITY, CA |
Other filings by this issuer (1)
More